Literature DB >> 28341533

Epidemiology of infectious encephalitis causes in 2016.

A Boucher1, J L Herrmann2, P Morand3, R Buzelé4, Y Crabol5, J P Stahl6, A Mailles7.   

Abstract

We performed a literature search in the Medline database, using the PubMed website. The incidence of presumably infectious encephalitis is estimated at 1.5-7 cases/100,000 inhabitants/year, excluding epidemics. Infectious encephalitis and immune-mediated encephalitis share similar clinical signs and symptoms. The latter accounts for a significant proportion of presumably infectious encephalitis cases without any established etiological diagnosis; as shown from a prospective cohort study where 21% of cases were due to an immune cause. Several infectious agents are frequently reported in all studies: Herpes simplex virus (HSV) is the most frequent pathogen in 65% of studies, followed by Varicella-zoster virus (VZV) in several studies. Enteroviruses are also reported; being the most frequent viruses in two studies, and the 2nd or 3rd viruses in five other studies. There are important regional differences, especially in case of vector-borne transmission: Asia and the Japanese encephalitis virus, Eastern and Northern Europe/Eastern Russia and the tick-borne encephalitis virus, Northern America and Flavivirus or Alphavirus. Bacteria can also be incriminated: Mycobacterium tuberculosis and Listeria monocytogenes are the most frequent, after HSV and VZV, in a French prospective study. The epidemiology of encephalitis is constantly evolving. Epidemiological data may indicate the emergence and/or dissemination of new causative agents. The dissemination and emergence of causative agents are fostered by environmental, social, and economical changes, but prevention programs (vaccination, vector controls) help reduce the incidence of other infectious diseases and associated encephalitis (e.g., measles).
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Emerging infections; Encephalitis; Encéphalite; Enterovirus; Entérovirus; Epidemiology; HSV; Infections émergentes; VZV; Épidémiologie

Mesh:

Year:  2017        PMID: 28341533     DOI: 10.1016/j.medmal.2017.02.003

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  35 in total

1.  The Insomnia Plague in Fictional Macondo.

Authors:  Alejandro Velásquez-Torres; Andrés Díaz-Forero; Claudia Talero-Gutiérrez
Journal:  Perm J       Date:  2020

2.  Impact of a multiplex PCR assay (FilmArray®) on the management of patients with suspected central nervous system infections.

Authors:  Marine Cailleaux; Benoît Pilmis; Assaf Mizrahi; Julie Lourtet-Hascoet; Jean-Claude Nguyen Van; Lilian Alix; Carine Couzigou; Barbara Vidal; Pierre Tattevin; Alban Le Monnier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-12       Impact factor: 3.267

Review 3.  Genomic and Metagenomic Approaches for Predictive Surveillance of Emerging Pathogens and Antibiotic Resistance.

Authors:  Kimberley V Sukhum; Luke Diorio-Toth; Gautam Dantas
Journal:  Clin Pharmacol Ther       Date:  2019-07-22       Impact factor: 6.875

4.  Acute Coxsackievirus B3-induced meningo-cerebellitis in an immunocompetent adult patient.

Authors:  M Chung; L Andreoletti; Y N'Guyen; S Soize; F Bani-Sadr; M Hentzien
Journal:  J Neurovirol       Date:  2022-10-04       Impact factor: 3.739

5.  Acute retinal necrosis following herpes simplex encephalitis: a nationwide survey in Japan.

Authors:  Daisuke Todokoro; Satoshi Kamei; Hiroshi Goto; Yoshio Ikeda; Hiroshi Koyama; Hideo Akiyama
Journal:  Jpn J Ophthalmol       Date:  2019-05-03       Impact factor: 2.447

6.  Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.

Authors:  Debra C Quenelle; Alexander Birkmann; Thomas Goldner; Tamara Pfaff; Holger Zimmermann; Susanne Bonsmann; Deborah J Collins; Terri L Rice; Mark N Prichard
Journal:  Antiviral Res       Date:  2017-11-04       Impact factor: 5.970

7.  Herpes simplex virus (HSV) encephalitis in a young man: an unusual course.

Authors:  Amos Lal; Megha C Dhamne; Andrew C Hui; Aftab Ahmad
Journal:  BMJ Case Rep       Date:  2018-02-24

8.  Characteristics and outcome of varicella-zoster virus central nervous system infections in adults.

Authors:  A Le Bot; A Ballerie; C Pronier; F Bénézit; F Reizine; M Tas; P Jégo; M Revest; Y Le Tulzo; P Fillâtre; Pierre Tattevin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-28       Impact factor: 3.267

9.  Meningitis, meningoencephalitis and encephalitis in Bern: an observational study of 258 patients.

Authors:  Anamaria Ungureanu; Julia van der Meer; Antonela Bicvic; Lena Abbuehl; Gabriele Chiffi; Léonore Jaques; Franziska Suter-Riniker; Stephen L Leib; Claudio L A Bassetti; Anelia Dietmann
Journal:  BMC Neurol       Date:  2021-12-06       Impact factor: 2.474

10.  Assessment of Magnetic Resonance Imaging Changes and Functional Outcomes Among Adults With Severe Herpes Simplex Encephalitis.

Authors:  Benjamine Sarton; Pierre Jaquet; Djida Belkacemi; Etienne de Montmollin; Fabrice Bonneville; Charline Sazio; Aurelien Frérou; Marie Conrad; Delphine Daubin; Russell Chabanne; Laurent Argaud; Frédéric Dailler; Noëlle Brulé; Nicolas Lerolle; Quentin Maestraggi; Julien Marechal; Pierre Bailly; Keyvan Razazi; Francois Mateos; Bertrand Guidet; Albrice Levrat; Vincent Susset; Alexandre Lautrette; Jean-Paul Mira; Ahmed El Kalioubie; Alexandre Robert; Alexandre Massri; Jean François Albucher; Jean Marc Olivot; Jean Marie Conil; Lila Boudma; Jean-François Timsit; Romain Sonneville; Stein Silva
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.